ETNB: 89bio, Inc. Stock

by  •  • Comments Off on ETNB: 89bio, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,498.78
Enterprise Value ($M) 1,219.32
Book Value ($M) 400.79
Book Value / Share 3.34
Price / Book 3.74
NCAV ($M) 603.37
NCAV / Share 4.12
Price / NCAV 2.48

Profitability (mra)
Return on Invested Capital (ROIC) -0.88
Return on Assets (ROA) -0.67
Return on Equity (ROE) -0.76

Liquidity (mrq)
Quick Ratio 18.03
Current Ratio 18.03

Balance Sheet (mrq) ($M)
Current Assets 682.94
Assets 685.03
Liabilities 79.57
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -384.66
Net Income -367.08

Cash Flow Statement (mra) ($M)
Cash From Operations -367.82
Cash from Investing -40.86
Cash from Financing 218.59

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
05-15 13G/A Rtw Investments, Lp 1.30 -73.33
05-15 13G/A Deep Track Capital, LP 9.18 113.28
05-14 13G/A Janus Henderson Group Plc 14.00 1.03
05-02 13G/A Suvretta Capital Management, Llc 9.90 43.21
03-03 13D/A Ra Capital Management, L.p. 13.70 0.00
02-14 13G/A Biotechnology Value Fund L P 3.60 -36.38
11-08 13G/A BlackRock, Inc. 7.10 0.00
10-17 13G/A State Street Corp 3.10 -39.78

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2025-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-06-06 229,343 1,382,768 16.59
2025-06-05 210,801 1,811,968 11.63
2025-06-04 399,165 2,554,563 15.63
2025-06-03 272,740 1,243,908 21.93
2025-06-02 427,939 1,917,000 22.32

(click for more detail)

Similar Companies
CVAC – CureVac N.V. EOLS – Evolus, Inc.
ESPR – Esperion Therapeutics, Inc. ETON – Eton Pharmaceuticals, Inc.
FATE – Fate Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io